Opportunity

Simpler Grants.gov #PAR-26-071

Forecasted Grant for Access to Biological Testing Facility for Contraception and Reproductive Health Research

Buyer

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Posted

September 15, 2025

Respond By

January 05, 2026

Identifier

PAR-26-071

NAICS

541714

This forecasted opportunity from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at NIH will provide access to a Biological Testing Facility (BTF) for research in contraception and reproductive health. - Government Buyer: - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH) - Purpose and Scope: - Grant for access to a state-of-the-art Biological Testing Facility - Supports product development in contraception and reproductive health for both women and men - Enables research on innovative and validated methods for fertility regulation and new reproductive health therapies - Eligibility: - Open to government entities, businesses, nonprofits, educational institutions, and other organizations - Products/Services Requested: - Access to the Biological Testing Facility (no specific products, part numbers, or quantities specified) - Unique Requirements: - Opportunity is for facility access and research support, not for procurement of goods - Applications are not yet being solicited; this is an advance notice to allow preparation - OEMs and Vendors: - No specific OEMs or vendors are mentioned, as this is a grant for facility access - Place of Performance: - National Institutes of Health (NIH)

Description

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) plans to publish a Notice of Funding Opportunity (NOFO) to solicit applications for access to a state-of-the-art Biological Testing Facility (BTF) aimed at advancing contraceptive and reproductive health product development. This opportunity addresses the critical need for fertility regulation methods suitable for both women and men throughout their reproductive lives and supports the development of new reproductive health therapies. Eligible investigators with innovative and validated methods for future clinical development are encouraged to apply. The opportunity will use the NIH X01 activity code to invite eligible institutions to seek access to NIH research resources. Applications are not currently being solicited; this notice is to allow potential applicants time to prepare responsive projects.

View original listing